- Home
- LUCD vs NB Comparison
LUCD vs NB Comparison
Compare LUCD & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- NB
- Stock Information
- Founded
- LUCD 2018
- NB 1987
- Country
- LUCD United States
- NB United States
- Employees
- LUCD N/A
- NB N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NB Metal Mining
- Sector
- LUCD Health Care
- NB Basic Materials
- Exchange
- LUCD Nasdaq
- NB Nasdaq
- Market Cap
- LUCD 140.7M
- NB 139.3M
- IPO Year
- LUCD 2021
- NB N/A
- Fundamental
- Price
- LUCD $1.16
- NB $2.33
- Analyst Decision
- LUCD Strong Buy
- NB Strong Buy
- Analyst Count
- LUCD 4
- NB 2
- Target Price
- LUCD $3.94
- NB $4.13
- AVG Volume (30 Days)
- LUCD 1.5M
- NB 1.1M
- Earning Date
- LUCD 08-11-2025
- NB 05-08-2025
- Dividend Yield
- LUCD N/A
- NB N/A
- EPS Growth
- LUCD N/A
- NB N/A
- EPS
- LUCD N/A
- NB N/A
- Revenue
- LUCD $4,173,000.00
- NB N/A
- Revenue This Year
- LUCD $91.46
- NB N/A
- Revenue Next Year
- LUCD $213.42
- NB N/A
- P/E Ratio
- LUCD N/A
- NB N/A
- Revenue Growth
- LUCD 39.89
- NB N/A
- 52 Week Low
- LUCD $0.72
- NB $1.27
- 52 Week High
- LUCD $1.80
- NB $4.15
- Technical
- Relative Strength Index (RSI)
- LUCD 42.03
- NB 42.67
- Support Level
- LUCD $1.13
- NB $2.54
- Resistance Level
- LUCD $1.21
- NB $2.85
- Average True Range (ATR)
- LUCD 0.07
- NB 0.20
- MACD
- LUCD -0.01
- NB -0.04
- Stochastic Oscillator
- LUCD 28.57
- NB 1.28
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.